{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:24:23Z","timestamp":1773800663316,"version":"3.50.1"},"reference-count":61,"publisher":"Codon Publications","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergologia et Immunopathologia"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.aller.2020.05.002","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T07:05:46Z","timestamp":1593759946000},"page":"507-517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?"],"prefix":"10.15586","volume":"48","author":[{"given":"A.R.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3532-0018","authenticated-orcid":false,"given":"R.S.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Medhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6228","reference":[{"key":"10.1016\/j.aller.2020.05.002_bib0005","unstructured":"COVID-19 coronavirus pandemic. https:\/\/www.worldometers.info\/coronavirus\/ (accessed 27 April 2020)."},{"key":"10.1016\/j.aller.2020.05.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat Rev Microbiol."},{"key":"10.1016\/j.aller.2020.05.002_bib0015","first-page":"30154","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","author":"Chan","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.aller.2020.05.002_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhin.2015.08.027","article-title":"Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination","volume":"92","author":"Otter","year":"2016","journal-title":"J Hosp Infect."},{"key":"10.1016\/j.aller.2020.05.002_bib0025","doi-asserted-by":"crossref","DOI":"10.1086\/422652","article-title":"Severe acute respiratory syndrome coronavirus on hospital surfaces","volume":"39","author":"Dowell","year":"2004","journal-title":"Clin Infect Dis."},{"issue":"Mar (7798)","key":"10.1016\/j.aller.2020.05.002_bib0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature."},{"issue":"Sep (18)","key":"10.1016\/j.aller.2020.05.002_bib0035","doi-asserted-by":"crossref","first-page":"11892","DOI":"10.1128\/JVI.79.18.11892-11900.2005","article-title":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms","volume":"79","author":"Kan","year":"2005","journal-title":"J Virol."},{"issue":"Mar 9","key":"10.1016\/j.aller.2020.05.002_bib0040","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","author":"Walls","year":"2020","journal-title":"Cell."},{"issue":"Aug (105)","key":"10.1016\/j.aller.2020.05.002_bib0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/bs.aivir.2019.08.002","article-title":"Structural insights into coronavirus entry","volume":"22","author":"Tortorici","year":"2019","journal-title":"Adv Virus Res."},{"issue":"Dec (12)","key":"10.1016\/j.aller.2020.05.002_bib0050","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin Microbiol Infect."},{"issue":"Mar (3)","key":"10.1016\/j.aller.2020.05.002_bib0055","article-title":"The BCG World Atlas: a database of global BCG vaccination policies and practices","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.aller.2020.05.002_bib0060","first-page":"253","article-title":"BCG immunization: review of past experience, current use, and future prospects","volume":"15","author":"Brewer","year":"1995","journal-title":"Curr Clin Topics Infect Dis."},{"issue":"Jul (3 Suppl)","key":"10.1016\/j.aller.2020.05.002_bib0065","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.2223\/JPED.1499","article-title":"BCG vaccine: efficacy\u202fand indications for vaccination and revaccination","volume":"82","author":"Barreto","year":"2006","journal-title":"J Pediatr (Rio J)."},{"key":"10.1016\/j.aller.2020.05.002_bib0070","unstructured":"Global tuberculosis control: surveillance, planning, financing. WHO report 2005. Geneva, World Health Organization (WHO\/HTM\/TB\/2005.349)."},{"key":"10.1016\/j.aller.2020.05.002_bib0075","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA."},{"key":"10.1016\/j.aller.2020.05.002_bib0080","first-page":"200","article-title":"Does the efficacy of BCG decline with time since vaccination?","volume":"2","author":"Sterne","year":"1998","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.aller.2020.05.002_bib0085","first-page":"41","article-title":"Tuberculosis control among North American Indians","volume":"45","author":"Townsend","year":"1942","journal-title":"AmRev Tuberc."},{"key":"10.1016\/j.aller.2020.05.002_bib0090","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archinte.1958.00260170037006","article-title":"A twenty year appraisal of BCG vaccination in the control of tuberculosis","volume":"101","author":"Aronson","year":"1958","journal-title":"Arch Intern Med."},{"issue":"May (17)","key":"10.1016\/j.aller.2020.05.002_bib0095","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study","volume":"291","author":"Aronson","year":"2004","journal-title":"Jama."},{"issue":"Jan","key":"10.1016\/j.aller.2020.05.002_bib0100","article-title":"Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study","author":"Miller","year":"2020","journal-title":"medRxiv."},{"issue":"Oct (41)","key":"10.1016\/j.aller.2020.05.002_bib0105","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1016\/j.vaccine.2015.07.103","article-title":"Management and outcome of Bacille Calmette-Gu\u00e9rin vaccine adverse reactions","volume":"33","author":"Venkataraman","year":"2015","journal-title":"Vaccine."},{"issue":"Jan (1)","key":"10.1016\/j.aller.2020.05.002_bib0110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe."},{"issue":"Dec (12)","key":"10.1016\/j.aller.2020.05.002_bib0115","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/infdis\/jiv332","article-title":"BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study","volume":"212","author":"Leentjens","year":"2015","journal-title":"J Infect Dis."},{"issue":"Aug (2)","key":"10.1016\/j.aller.2020.05.002_bib0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/infdis\/136.2.171","article-title":"Nonspecific protection of mice against influenza virus infection by local or systemic immunization with Bacille Calmette-Guerin","volume":"136","author":"Spencer","year":"1977","journal-title":"J Infect Dis."},{"issue":"Sep (6)","key":"10.1016\/j.aller.2020.05.002_bib0125","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/520094","article-title":"Tumor necrosis factor-\u03b1 and interleukin-1\u03b2 play a critical role in the resistance against lethal herpes simplex virus encephalitis","volume":"196","author":"Sergerie","year":"2007","journal-title":"J Infect Dis."},{"key":"10.1016\/j.aller.2020.05.002_bib0130","unstructured":"Clinicaltrials.gov. https:\/\/clinicaltrials.gov\/ct2\/results?cond=Covid-19&term=BCG&cntry=&state=&city=&dist= (accessed 20 April 2020)."},{"key":"10.1016\/j.aller.2020.05.002_bib0135","unstructured":"Covid-19 minigen vaccine. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04276896?term=minigene&cond=Covid-19&draw=2&rank=1 (accessed 20 April 2020)."},{"key":"10.1016\/j.aller.2020.05.002_bib0140","unstructured":"Covid-19 aPAC vaccine. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04299724?term=minigene&cond=Covid-19&draw=2&rank=2 (accessed 20 April 2020)."},{"key":"10.1016\/j.aller.2020.05.002_bib0145","unstructured":"Ad5-nCoV vaccine. https:\/\/clinicaltrials.gov\/ct2\/results?cond=Covid-19&term=Ad5-nCoV&cntry=&state=&city=&dist= (accessed 20 April 2020)."},{"key":"10.1016\/j.aller.2020.05.002_bib0150","unstructured":"bacTRL spike vaccine. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04334980?term=bacTRL+spike&cond=covid-19&draw=2&rank=1 (accessed 20 April 2020)."},{"key":"10.1016\/j.aller.2020.05.002_bib0155","unstructured":"mRNA-1273 vaccine. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04283461?term=mRNA-1273&cond=Covid-19&draw=2&rank=1 (accessed 20 April 2020)."},{"issue":"Dec (12)","key":"10.1016\/j.aller.2020.05.002_bib0160","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nbt.2436","article-title":"Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection","volume":"30","author":"Petsch","year":"2012","journal-title":"Nat Biotechnol."},{"issue":"Dec (12)","key":"10.1016\/j.aller.2020.05.002_bib0165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.molmed.2013.09.002","article-title":"Challenges and advances towards the rational design of mRNA vaccines","volume":"19","author":"Pollard","year":"2013","journal-title":"Trends Mol Med."},{"issue":"Sep","key":"10.1016\/j.aller.2020.05.002_bib0170","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3389\/fimmu.2017.01134","article-title":"What have we learnt about BCG vaccination in the last 20 years?","volume":"8","author":"Dockrell","year":"2017","journal-title":"Front Immunol."},{"issue":"Apr","key":"10.1016\/j.aller.2020.05.002_bib0175","first-page":"407","article-title":"Immune responses to bacillus Calmette\u2013Gu\u00e9rin vaccination: why do they fail to protect against Mycobacterium tuberculosis?","volume":"8","author":"Moliva","year":"2017","journal-title":"Front Immunol."},{"issue":"Mar (6)","key":"10.1016\/j.aller.2020.05.002_bib0180","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","article-title":"Toll-like receptors in antiviral innate immunity","volume":"426","author":"Lester","year":"2014","journal-title":"J Mol Biol."},{"key":"10.1016\/j.aller.2020.05.002_bib0185","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.1128\/JVI.76.17.8729-8736.2002","article-title":"Hemagglutinin protein of wild-typemeasles virus activates toll-like receptor 2 signaling","volume":"76","author":"Bieback","year":"2002","journal-title":"J Virol."},{"key":"10.1016\/j.aller.2020.05.002_bib0190","doi-asserted-by":"crossref","first-page":"11160","DOI":"10.1128\/JVI.03099-12","article-title":"Rotavirus NSP4 triggers secretion of proinflammatory cytokines from macrophages via Toll-like receptor 2","volume":"87","author":"Ge","year":"2013","journal-title":"J Virol."},{"key":"10.1016\/j.aller.2020.05.002_bib0195","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/80833","article-title":"Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus","volume":"1","author":"Kurt-Jones","year":"2000","journal-title":"Nat Immunol."},{"key":"10.1016\/j.aller.2020.05.002_bib0200","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00109-004-0620-6","article-title":"Reading the viral signature by Toll-like receptors and other pattern recognition receptors","volume":"83","author":"Mogensen","year":"2005","journal-title":"J Mol Med (Berl)."},{"key":"10.1016\/j.aller.2020.05.002_bib0205","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3389\/fimmu.2019.01144","article-title":"Bacterial protein toll-like-receptor agonists: a novel perspective on vaccine adjuvants","volume":"10","author":"Kumar","year":"2019","journal-title":"Front Immunol."},{"issue":"Jul (1)","key":"10.1016\/j.aller.2020.05.002_bib0210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1189\/jlb.0105037","article-title":"Mycobacterium bovis Bacillus Calmette\u2010Gu\u00e9rin infects DC-SIGN\u2013dendritic cell and causes the inhibition of IL-12 and the enhancement of IL-10 production","volume":"78","author":"Gagliardi","year":"2005","journal-title":"J Leukoc Biol."},{"issue":"Dec (12)","key":"10.1016\/j.aller.2020.05.002_bib0215","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1128\/IAI.68.12.6883-6890.2000","article-title":"Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors","volume":"68","author":"Tsuji","year":"2000","journal-title":"Infect Immun."},{"issue":"May (5)","key":"10.1016\/j.aller.2020.05.002_bib0220","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1172\/JCI97508","article-title":"Mycobacterial growth inhibition is associated with trained innate immunity","volume":"128","author":"Joosten","year":"2018","journal-title":"J Clin Invest."},{"issue":"Dec (11)","key":"10.1016\/j.aller.2020.05.002_bib0225","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.4049\/jimmunol.181.11.7948","article-title":"Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis","volume":"181","author":"Bertholet","year":"2008","journal-title":"J Immunol."},{"key":"10.1016\/j.aller.2020.05.002_bib0230","first-page":"172","article-title":"Tuberculosis vaccines: time to think about the next generation","volume":"25","author":"Kaufmann","year":"2013"},{"issue":"Oct (10)","key":"10.1016\/j.aller.2020.05.002_bib0235","article-title":"BCG skin infection triggers IL-1R-MyD88-dependent migration of EpCAMlow CD11bhigh skin dendritic cells to draining lymph node during CD4+ T-cell priming","volume":"11","author":"Bollampalli","year":"2015","journal-title":"PLoS Pathog."},{"issue":"May","key":"10.1016\/j.aller.2020.05.002_bib0240","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.molimm.2019.02.021","article-title":"The Mycobacterium tuberculosis glycoprotein Rv1016c protein inhibits dendritic cell maturation, and impairs Th1\/Th17 responses during mycobacteria infection","volume":"109","author":"Su","year":"2019","journal-title":"Mol Immunol."},{"issue":"Apr (4)","key":"10.1016\/j.aller.2020.05.002_bib0245","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/JLB.4A0917-363RR","article-title":"Deletion of BCG Hip1 protease enhances dendritic cell and CD4 T cell responses","volume":"103","author":"Bizzell","year":"2018","journal-title":"J Leukoc Biol."},{"issue":"Apr (5)","key":"10.1016\/j.aller.2020.05.002_bib0250","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.micinf.2005.12.023","article-title":"A role for dendritic cells in the dissemination of mycobacterial infection","volume":"8","author":"Humphreys","year":"2006","journal-title":"Microbes Infect."},{"issue":"Apr (4)","key":"10.1016\/j.aller.2020.05.002_bib0255","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/eji.201445132","article-title":"TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN","volume":"45","author":"Temizoz","year":"2015","journal-title":"Eur J Immunol."},{"issue":"Jun (6)","key":"10.1016\/j.aller.2020.05.002_bib0260","article-title":"Novel vaccination strategies against tuberculosis","volume":"4","author":"Andersen","year":"2014","journal-title":"Cold Spring Harbor Perspect Med."},{"issue":"Dec (1)","key":"10.1016\/j.aller.2020.05.002_bib0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1196\/annals.1358.010","article-title":"The immune response to BCG vaccination of newborns","volume":"1062","author":"Hanekom","year":"2005","journal-title":"Ann N Y Acad Sci."},{"issue":"Oct (8)","key":"10.1016\/j.aller.2020.05.002_bib0270","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.4049\/jimmunol.177.8.5647","article-title":"Bacillus Calmette Guerin vaccination of human newborns induces a specific, functional CD8+ T cell response","volume":"177","author":"Murray","year":"2006","journal-title":"J Immunol."},{"issue":"Apr (7)","key":"10.1016\/j.aller.2020.05.002_bib0275","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/infdis\/jis941","article-title":"Longitudinal changes in CD4+ T-cell memory responses induced by BCG vaccination of newborns","volume":"207","author":"Soares","year":"2013","journal-title":"J Infect Dis."},{"issue":"Aug (4)","key":"10.1016\/j.aller.2020.05.002_bib0280","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1365-2567.1999.00840.x","article-title":"Characterization of the memory\/activated T cells that mediate the long-lived host response against tuberculosis after bacillus Calmette\u2013Gu\u00e9rin or DNA vaccination","volume":"97","author":"Silva","year":"1999","journal-title":"Immunology."},{"key":"10.1016\/j.aller.2020.05.002_bib0285","series-title":"WHO guidelines on tuberculosis infection prevention and control: 2019 update","author":"World Health Organization","year":"2019"},{"issue":"Sep (9)","key":"10.1016\/j.aller.2020.05.002_bib0290","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/thorax.56.9.741","article-title":"BCG re-vaccination","volume":"56","author":"Grime","year":"2001","journal-title":"Thorax."},{"issue":"Oct (10)","key":"10.1016\/j.aller.2020.05.002_bib0300","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/501976","article-title":"Tuberculin skin test conversion among medical students at a teaching hospital in Rio de Janeiro, Brazil","volume":"23","author":"Silva","year":"2002","journal-title":"Infect Control Hosp Epidemiol."},{"issue":"Sep (Supplement_3)","key":"10.1016\/j.aller.2020.05.002_bib0305","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1086\/314072","article-title":"Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature","volume":"31","author":"Brewer","year":"2000","journal-title":"Clin Infect Dis."},{"issue":"Oct (10)","key":"10.1016\/j.aller.2020.05.002_bib0310","first-page":"150","article-title":"Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosis","volume":"17","author":"Komine-Aizawa","year":"2010","journal-title":"Clin Vaccine Immunol."}],"container-title":["Allergologia et Immunopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054620301063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054620301063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T22:52:31Z","timestamp":1609455151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301054620301063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0301054620301063"],"URL":"https:\/\/doi.org\/10.1016\/j.aller.2020.05.002","relation":{},"ISSN":["0301-0546"],"issn-type":[{"value":"0301-0546","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?","name":"articletitle","label":"Article Title"},{"value":"Allergologia et Immunopathologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aller.2020.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 SEICAP. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}